Olanzapine Injection, Powder, For Solution
Product Images NDC 0143-9199

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 0143-9199). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure diagram of Olanzapine, showing its molecular framework including nitrogen, sulfur atoms, and methyl groups typical of this antipsychotic agent.*

FDA Label Image

Container Label (OLANZAPINE FOR INJECTION 10 mg/vial)

Label for Olanzapine for Injection 10 mg per vial, sterile single-dose vial intended for intramuscular use. The label shows it is manufactured by Qilu Pharmaceutical Co., Ltd. for Hikma Pharmaceuticals USA Inc. The vial contains 1 dose and is for prescription use only. The label includes an NDC and a barcode.*

FDA Label Image

Carton Label (OLANZAPINE FOR INJECTION 10 mg/vial)

Label for Olanzapine for Injection, 10 mg per vial, sterile single-dose vial for intramuscular use only. It is manufactured by Hikma Pharmaceuticals USA Inc. The label includes dosage information, storage instructions, and mentions the product is Rx Only with a package size of 1 vial.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.